ELV Q3 2024 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q3 2024 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$45.1B+5.4% YoY

Gross Profit

$12.2B27.0% margin

Operating Income

$1.7B3.8% margin

Net Income

$1.0B2.3% margin

EPS (Diluted)

$4.36

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

$2.7B

Free Cash Flow

$2.3B

Stock-Based Comp.

$66M

Balance Sheet

Total Assets

$116.5B

Total Liabilities

$72.7B

Stockholders' Equity

$43.8B

Cash & Equivalents

$7.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45.1B	$42.8B	+5.4%
Gross Profit	$12.2B	$12.2B	-0.4%
Operating Income	$1.7B	$1.9B	-10.5%
Net Income	$1.0B	$1.3B	-21.2%

Revenue Segments

Health Benefits Segment

$38.3B58%

Carelon Services Segment

$27.6B42%